Acepodia
Biotechnology ResearchView the employees at
Acepodia-
Joe Lin Acepodia CMC scientist
-
Xizhi District, New Taipei City, Taiwan
-
Rising Star
Sen Han Yang Research Scientist at Acepodia-
Davis, California, United States
-
Rising Star
Ann Liu Accounting Manager-
Taipei, Taipei City, Taiwan
-
Rising Star
David Lin Acepodia Business Development Manager-
Taipei City, Taipei City, Taiwan
-
Rising Star
Overview
Acepodia is a clinical-stage biotechnology company developing innovative and highly effective cell therapies for cancer that are broadly accessible for patients. Leveraging its Antibody-Cell Conjugation (ACC) technology, the company links tumor-targeting antibodies to its proprietary immune effector cells, such as gamma delta T cells and natural killer (NK) cells to create novel antibody cell effector (ACE) therapies, which have increased binding strength against tumors that express low levels of tumor antigens. Acepodia is made up of seasoned leadership and scientific experts dedicated to advancing its robust pipeline of off-the-shelf ACE therapies with the potential to bring powerful, accessible cell therapies to a broad population of patients across a variety of solid tumors and hematologic cancers.
-